High
21.800
Open
21.650
VWAP
21.41
Vol
46.90K
Mkt Cap
534.87M
Low
21.180
Amount
1.00M
EV/EBITDA(TTM)
--
Total Shares
23.83M
EV
539.15M
EV/OCF(TTM)
--
P/S(TTM)
2.43
OrthoPediatrics Corp. is an orthopedic company focused on advancing the field of pediatric orthopedics. It is primarily engaged in designing, developing, and marketing anatomically appropriate implants and devices for children with orthopedic conditions, giving pediatric orthopedic surgeons and caregivers. It operates through the OrthoPediatrics Segment, which designs, develops and markets anatomically appropriate implants and devices for children with orthopedic problems. It offers a range of products, such as PediLoc , PediPlates , Cannulated Screws, PediFlex nail, PediNail , PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediatric Nailing Platform Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, ApiFix Mid-C System and Mitchell Ponseti specialized bracing products to various hospitals and medical facilities throughout the United States and various international markets.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q1
FY2025Q2
FY2025Q3
51.68M
+15.66%
--
--
61.57M
+16.61%
--
--
63.89M
+17.06%
--
--
Estimates Revision
The market is revising Downward the revenue expectations for OrthoPediatrics Corp. (KIDS) for FY2025, with the revenue forecasts being adjusted by -0.81% over the past three months. During the same period, the stock price has changed by -14.25%.
Revenue Estimates for FY2025
Revise Downward
-0.81%
In Past 3 Month
Stock Price
Go Down
-14.25%
In Past 3 Month
7 Analyst Rating
74.91% Upside
Wall Street analysts forecast KIDS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for KIDS is 37.57 USD with a low forecast of 24.00 USD and a high forecast of 50.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
6 Buy
1 Hold
0 Sell
Strong Buy
74.91% Upside
Current: 21.480
Low
24.00
Averages
37.57
High
50.00
74.91% Upside
Current: 21.480
Low
24.00
Averages
37.57
High
50.00
Truist Securities
Richard Newitter
Hold
Maintains
$26 → $24
2025-04-11
Reason
Truist Securities
Richard Newitter
Price Target
$26 → $24
2025-04-11
Maintains
Hold
Reason
Truist analyst Richard Newitter lowered the firm's price target on OrthoPediatrics to $24 from $26 and keeps a Hold rating on the shares as part of a broad research note previewing Q1 results in Medical Technology. The group's revenue and earnings are less at risk than it could be for a number of other sub-sectors, which will likely keep investors relatively interested in the space even with some tariff choppiness in the backdrop, though the firm is also bracing for cautious 2025 outlooks as companies and models will likely begin to dial-in some macro uncertainty, the analyst tells investors in a research note.
Needham
Mike Matson
Strong Buy
Reiterates
$42
2025-04-09
Reason
Needham
Mike Matson
Price Target
$42
2025-04-09
Reiterates
Strong Buy
Reason
Lake Street
Ben Haynor
Strong Buy
Initiates
$37
2025-04-07
Reason
Lake Street
Ben Haynor
Price Target
$37
2025-04-07
Initiates
Strong Buy
Reason
Lake Street initiated coverage of OrthoPediatrics with a Buy rating and $37 price target. OrthoPediatrics has proven out its founding thesis that a focused pediatric orthopedics firm is needed and can generate strong economic returns, says the analyst, who argues that the company "occupies a Goldilocks position in an overlooked market."
Citizens Capital Markets
David Turkaly
Buy
Reiterates
$50
2025-03-21
Reason
Citizens Capital Markets
David Turkaly
Price Target
$50
2025-03-21
Reiterates
Buy
Reason
Needham
Mike Matson
Strong Buy
Reiterates
$42
2025-03-05
Reason
Needham
Mike Matson
Price Target
$42
2025-03-05
Reiterates
Strong Buy
Reason
Stifel
Rick Wise
Strong Buy
Maintains
$40 → $32
2025-03-05
Reason
Stifel
Rick Wise
Price Target
$40 → $32
2025-03-05
Maintains
Strong Buy
Reason
Stifel lowered the firm's price target on OrthoPediatrics to $32 from $40 and keeps a Buy rating on the shares. Considering the company's mid-January preannouncement and somewhat cautious growth outlook, the Q4 earnings call was "more encouraging than we expected," the analyst tells investors. The firm left the OrthoPediatrics earnings call "feeling both encouraged and excited for the 2025 year," the analyst added.
See All Ratings
Valuation Metrics
The current forward P/E ratio for OrthoPediatrics Corp (KIDS.O) is -16.62, compared to its 5-year average forward P/E of -48.27. For a more detailed relative valuation and DCF analysis to assess OrthoPediatrics Corp 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
-48.27
Current PE
-16.62
Overvalued PE
-30.87
Undervalued PE
-65.66
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
359.34
Current EV/EBITDA
34.99
Overvalued EV/EBITDA
909.01
Undervalued EV/EBITDA
-190.34
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
Undervalued
5Y Average PS
6.99
Current PS
2.26
Overvalued PS
10.17
Undervalued PS
3.82
Financials
Annual
Quarterly
FY2024Q4
YoY :
+40.02%
52.67M
Total Revenue
FY2024Q4
YoY :
+6.20%
-8.57M
Operating Profit
FY2024Q4
YoY :
+140.16%
-16.07M
Net Income after Tax
FY2024Q4
YoY :
+137.93%
-0.69
EPS - Diluted
FY2024Q4
YoY :
-70.43%
-3.99M
Free Cash Flow
FY2024Q4
YoY :
-4.91%
67.53
Gross Profit Margin - %
FY2024Q4
YoY :
-33.80%
-20.49
FCF Margin - %
FY2024Q4
YoY :
+71.50%
-30.51
Net Margin - %
Trading Trends
Insider
Insiders areSelling! The selling amount has increased 146.33% over the last month.
Sold
0-3
Months
721.7K
USD
5
3-6
Months
0.0
USD
0
6-9
Months
293.0K
USD
1
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
1
21.0K
Volume
Months
6-9
0
0.0
Volume
Months
0-12
4
620.0K
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders areSelling! The selling amount has increased 146.33% over the last month.
Sold
0-3
Months
721.7K
USD
5
3-6
Months
0.0
USD
0
6-9
Months
293.0K
USD
1
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
KIDS News & Events
Events Timeline
2025-04-08 (ET)
2025-04-08
08:25:39
OrthoPediatrics announces U.S. launch of VerteGlide Spinal Growth Guidance
2025-03-04 (ET)
2025-03-04
16:15:25
OrthoPediatrics sees FY25 revenue $235M-$242M, consensus $240.78M
2025-03-04
16:13:56
OrthoPediatrics reports Q4 adjusted EPS (29c), consensus (26c)
Sign Up For More Events
Sign Up For More Events
News
5.0
04-08NewsfilterOrthoPediatrics Corp. Expands Scoliosis Portfolio with Launch of VerteGlide™ System
4.0
03-21BenzingaDemystifying OrthoPediatrics: Insights From 4 Analyst Reviews
5.0
03-18NASDAQ.COMInsider Sale: General Counsel and Secretary of $KIDS Sells 5,310 Shares
Sign Up For More News
People Also Watch
OMER
Omeros Corp
7.310
USD
0.00%
CLFD
Clearfield Inc
29.010
USD
-0.45%
NYMT
New York Mortgage Trust Inc
5.730
USD
+1.60%
LASR
nLIGHT Inc
7.730
USD
-1.15%
CRNC
Cerence Inc
9.470
USD
-2.47%
TBLD
Thornburg Income Builder Opportunities Trust
17.850
USD
+0.22%
OPAL
Opal Fuels Inc
1.725
USD
-0.86%
HNRG
Hallador Energy Co
14.560
USD
-0.88%
KULR
KULR Technology Group Inc
1.350
USD
0.00%
WLDN
Willdan Group Inc
39.220
USD
+2.16%
FAQ
What is OrthoPediatrics Corp (KIDS) stock price today?
The current price of KIDS is 21.48 USD — it has decreased -0.28 % in the last trading day.
What is OrthoPediatrics Corp (KIDS)'s business?
What is the price predicton of KIDS Stock?
What is OrthoPediatrics Corp (KIDS)'s revenue for the last quarter?
What is OrthoPediatrics Corp (KIDS)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for OrthoPediatrics Corp (KIDS)'s fundamentals?
How many employees does OrthoPediatrics Corp (KIDS). have?